Research and Markets Business Development and RD Database Breast Cancer

April 19 2005 Research and Markets httpwwwresearchandmarketscomreportsc15841 has announced the addition of Business Development and RD Database Breast cancer to their offering Business Development and RD Database Breast Cancer will provide you with both an update and a complete structure on competitors in this field and their recent advances on breast cancer drug development Including RD from industry as well as academic efforts connected to the private sector This report has been compiled to enable your independent and unbiased analysis of progress pitfalls and competition of drugs for the treatment of breast cancer Information on breast cancer in the database has carefully been selected and structured in the four areas of RD business interaction news and company profiles Example of candidates included The complete number of candidate drugs in clinical research for breast cancer are more than 150 and some of them are listed below Abraxane Alimta Arimidex Aromasin Avastin BMS21738001 BMS247550 CAELYX CCI779 Faslodex Femara Fenretinide Gleevec GTI2040 Herceptin Iressa ISIS2503 Lapatinib Nolvadex Sarasar SDX105 Tarceva Theratope Velcade Zarnestra Zoladex ZD0473 and many other that are in an earlier stage of development The database is structured into four sections RD activities Business interaction News Company profiles The RD information is structured into 11 searchable segments +3000 of records Investigator Drug name Combinatory drugs Developmental stage Indication Subindication Therapy given Drug Effects MechanismsTargets General comments Source of data Company profiles includes Company Contact details address phone fax email url Short company description Smart CDROM database Multiple search and sort functions included Company data is linked to search engines like Google and PubMed Directs you directly to corporate web pages from inside the application Found information is easily shared with others over email or in print Easy to use and navigate by In total more than 170 companies within the sphere of breast cancer have been analysed and the major companies are listed below American Bioscience AnorMED AstraZeneca Biomira Inc BristolMyers Squibb Eli Lilly and Company Genentech GlaxoSmithKline ISIS Pharmaceuticals Johnson and Johnson Lorus Therapeutics McNeil Pharmaceuticals Merck KgaA Millennium Pharmaceuticals NeoRx Novartis OSI Pharmaceuticals Pfizer Roche Salmedix ScheringPlough Wyeth For more information visit httpwwwresearchandmarketscomreportsc15841 Laura Wood Senior Manager Research and Markets email protected from spam bots Fax +353 1 4100 980

Research and Markets Business Development and RD Database Breast Cancer

4154 readers online...

Research and Markets Business Development and RD Database Breast Cancer

Search